39 results
2013: 5 MedTech Europe activities that will impact our industry for the years to come
The year is nearing its end and as I look at the christmas tree being put up, the smell of pinewood slowly filling our office’s reception area, I cannot help but think that 2013 was a crucial year for patients, healthcare systems and Europe as a whole. This past year was dominated by one topic of mastodont proportions, but other actions, activities and achievements have been just as important to us.
New rules, new markets – medical devices and diagnostics’ place in a changing Europe
Judging by the weather in Belgium (currently 10° and raining) you wouldn’t say it, but it’s almost summer. Well, at least according to the calendar. And apart from the supposed good weather, summer also brings with it a host of new information on the MedTech Forum. Speakers are being confirmed, registrations coming in and preparations being made. Less than 5 months from now, we will all be seeing each other again at the event no one in our industry can afford to miss. So what does the MedTech Forum hold in store this year.
Posted on 29.11.2012
When Good Medicine Isn’t Good Enough
Advances in in vitro HIV/AIDS diagnostics, combined with the development of highly effective antiretroviral (ARV) drugs, have significantly reduced the transmission of HIV from mother to baby and greatly improved health outcomes for mothers living with HIV. Simple and inexpensive tests screen for HIV within minutes, and point of care CD4 testing enables doctors to closely monitor a patient’s immune system to prescribe an effective combination of ARVs to keep mothers healthy during and after their pregnancy and their babies HIV-free. As a result, new pediatric HIV infections have nearly halved in the last eight years and the number of deaths each year attributed to AIDS-related causes dropped 24% since the peak in 2005, to approximately 1.7 million in 2011.
Sustainability’s promise for business opportunity and healthcare change
When we speak about healthcare in Europe, the word ‘sustainability’ is used often. From the outset of the economic crisis in 2008, policymakers, ministries of health, customers and payers all have focused on sustainable financial systems and sustainable healthcare systems – often as separate paths to achieve results. As budgets are shrinking, innovative ways to maintain current social and healthcare systems for the long term must be employed. At CleanMed Europe, a conference that brings environmental and healthcare issues together on the same agenda, I was pleased to see that a broader alternative discussion is emerging—one that marries financial and systemic sustainability in healthcare.
Posted on 08.06.2012
Will a European Network perform Medical Technology Assessments from an Ivory Tower?
The current voluntary cooperation of Health Technology Assessment (HTA) agencies organised within EUnetHTA indicates that HTA is a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related to the use of a health technology.
Posted on 10.04.2012
Let’s flip the European innovation model on its head
Innovation is synonymous with progress. Embracing innovation means embracing the need to improve the sustainability and efficiency of healthcare systems by encouraging new business models, unlocking new market opportunities and improving health outcomes. Uptake of innovation in technology and services, however, could be quicker on the European healthcare scene, with myriad barriers currently standing in the way.
Posted on 28.02.2012
Assessing the value of medical devices – it’s about more than just clinical effectiveness
Ever since the end of WWII, the reigning clinical philosophy was one whereby there was no limit on medical treatment. From the 80s onwards, this philosophy shifted towards a more balanced approach whereby the benefit of the treatment had to outweigh the potential risks associated with it, with evidence-based medicine being the concept used to assess a new treatment.
What is value in healthcare?
When one of the defining minds of business education in recent years turns his attention to healthcare then people would be wise to sit up and listen. Harvard Business School guru Michael Porter first entered the impenetrable world of health policy in 2006 in a book with colleague Elizabeth Teisberg entitled ‘Redefining health care: creating […]
Posted on 19.11.2010
Throwing the baby out with the bathwater
Health and Consumer Affairs Commissioner, John Dalli, made a typically balanced speech about his vision for health on the European agenda at a meeting organised by Friends of Europe. The high-level summit entitled ‘An Innovative Healthcare Agenda for Europe’, was held this week in the magnificent setting of the Bibliotheque Solvay, in the heart of […]